New study seeks to predict brain tumor changes with simple scans and blood tests

NCT ID NCT07447531

Recruiting now Knowledge-focused Sponsor: John M. Buatti Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at whether special MRI scans and blood tests can help predict how a type of aggressive brain tumor (malignant glioma) changes over time. Researchers will follow 15 adults with newly diagnosed tumors, using imaging and blood samples to track certain iron-related markers. The goal is to better understand tumor progression, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict how aggressive brain tumors might change over time, potentially guiding treatment decisions.
What could go wrong: This is a very small, early observational study with only 15 people. It is not testing a treatment, so it may not lead to direct patient benefits. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma glioma malignant glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT GLIOMA

Contacts and locations

Locations

University of Iowa Health Care
RECRUITING

Iowa City, Iowa, 52245, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.